Hims & Hers: Investor Deadline Approaching for Securities Fraud Lawsuit

Rosen Law Firm, a global investor rights law firm, has notified purchasers of Hims & Hers Health, Inc. (NYSE: HIMS) securities between August 4, 2025, and July 29, 2026, inclusive, of an important lead plaintiff deadline on November 2, 2026.

The lawsuit alleges that the company shared consumer health information with third-party advertising platforms and immediately charged consumers for prescriptions after they submitted intake forms, exposing Hims to regulatory scrutiny and potential penalties.

Investors who purchased Hims securities during the class period may be entitled to compensation without paying out-of-pocket fees through a contingency fee arrangement. Rosen Law Firm advises investors to select qualified counsel. A class action lawsuit has already been filed.

Those wishing to serve as lead plaintiff must move the Court no later than November 2, 2026. Investors can join the class action or remain an absent class member. According to the lawsuit, when the true details emerged, investors suffered damages.